Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

469 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.
Pal R, Venzon D, Santra S, Kalyanaraman VS, Montefiori DC, Hocker L, Hudacik L, Rose N, Nacsa J, Edghill-Smith Y, Moniuszko M, Hel Z, Belyakov IM, Berzofsky JA, Parks RW, Markham PD, Letvin NL, Tartaglia J, Franchini G. Pal R, et al. Among authors: berzofsky ja. J Virol. 2006 Apr;80(8):3732-42. doi: 10.1128/JVI.80.8.3732-3742.2006. J Virol. 2006. PMID: 16571790 Free PMC article.
Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.
Belyakov IM, Derby MA, Ahlers JD, Kelsall BL, Earl P, Moss B, Strober W, Berzofsky JA. Belyakov IM, et al. Among authors: berzofsky ja. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1709-14. doi: 10.1073/pnas.95.4.1709. Proc Natl Acad Sci U S A. 1998. PMID: 9465081 Free PMC article.
Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.
Belyakov IM, Wyatt LS, Ahlers JD, Earl P, Pendleton CD, Kelsall BL, Strober W, Moss B, Berzofsky JA. Belyakov IM, et al. Among authors: berzofsky ja. J Virol. 1998 Oct;72(10):8264-72. doi: 10.1128/JVI.72.10.8264-8272.1998. J Virol. 1998. PMID: 9733870 Free PMC article.
Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.
Arichi T, Saito T, Major ME, Belyakov IM, Shirai M, Engelhard VH, Feinstone SM, Berzofsky JA. Arichi T, et al. Among authors: berzofsky ja. Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):297-302. doi: 10.1073/pnas.97.1.297. Proc Natl Acad Sci U S A. 2000. Retraction in: Proc Natl Acad Sci U S A. 2001 May 8;98(10):5943. doi: 10.1073/pnas.101132998 PMID: 10618412 Free PMC article. Retracted.
Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates.
McGettigan JP, Foley HD, Belyakov IM, Berzofsky JA, Pomerantz RJ, Schnell MJ. McGettigan JP, et al. Among authors: berzofsky ja. J Virol. 2001 May;75(9):4430-4. doi: 10.1128/JVI.75.9.4430-4434.2001. J Virol. 2001. PMID: 11287595 Free PMC article.
469 results